This approach may be especially effective in tumors with non-functional PTEN, as it might overcome the limitations of immune checkpoint inhibitors and enhance anti-tumor immunity by modulating the immunosuppressive TME (29,33). The gene discussed is PTEN; the disease is neoplasm.